Difference between revisions of "Team:Fudan-CHINA"

Line 1: Line 1:
 +
{{Fudan-CHINA}}
 
<html>
 
<html>
−
<style type="text/css">
 
−
body,td,th {
 
−
font-family: Constantia, "Lucida Bright", "DejaVu Serif", Georgia, serif;
 
−
color: #727272;
 
−
}
 
−
</style>
 
−
<body bgcolor="#F1F1F1">
 
  
−
<img src='https://static.igem.org/mediawiki/2018/b/b4/T--Fudan-CHINA--background1.jpg'>
+
 
 +
<img src='https://static.igem.org/mediawiki/2018/b/b4/T--Fudan-CHINA--background1.jpg' width="800">
  
 
<br><br><br><br><br><br><br>
 
<br><br><br><br><br><br><br>
−
 
+
<img src='https://static.igem.org/mediawiki/2018/b/b4/T--Fudan-CHINA--logo2.jpg' width="200">
 
<div class="column full_size" >
 
<div class="column full_size" >
−
<table width="1200" border="0" align="center">
+
<table width="800" border="0" align="center">
 
   <tbody>
 
   <tbody>
 
     <tr>
 
     <tr>
 
       <td><h1>STEP</h1>
 
       <td><h1>STEP</h1>
−
        <img src='https://static.igem.org/mediawiki/2018/b/b4/T--Fudan-CHINA--logo2.jpg' width="200"></td>
+
</td>
 
     </tr>
 
     </tr>
 
     <tr>
 
     <tr>
Line 36: Line 31:
 
   <tbody>
 
   <tbody>
 
     <tr> </tr>
 
     <tr> </tr>
−
    <tr>
+
 
−
      <td>&nbsp;</td>
+
−
    </tr>
+
 
   </tbody>
 
   </tbody>
 
</table>
 
</table>
Line 54: Line 47:
  
  
−
<img src='https://static.igem.org/mediawiki/2018/f/f2/T--Fudan-CHINA--membrane.gif' width="1920">
+
<img src='https://static.igem.org/mediawiki/2018/f/f2/T--Fudan-CHINA--membrane.gif' width="800">
  
 
</html>
 
</html>

Revision as of 17:48, 25 July 2018








STEP

iGEM 2018 team:Fudan-CHINA

Description
Synthetic Transducer Engineering Platform (STEP)
As the primary cause of death, cancer has long been threatening life of human. Modular receptor systems have become a hotspot of cancer therapy, while existing synthetic systems (CAR-T, synNotch, etc) are only capable of recognising membrane protein rather than soluble ligands, which are also important targets. To address this problem, we designed Synthetic Transducer Engineering Platform (STEP), which is aimed to convert extracellular stimulation of soluble ligands into a reporter gene signal. STEP consists of two separate transmembrane chains, one with an intracellular domain of a transcription factor and the other with a protease. Binding of ligands and the two chains will lead to a cleavage event and release the transcription factor, thus triggering desired gene expression, e.g., secretion of drugs. With its extra- and intra-cellular domain being highly programmable, STEP provides a general yet orthogonal platform of ligand recognition, and a new approach of targeting therapy of cancer.